QQQ   424.07 (-0.42%)
AAPL   166.99 (-0.60%)
MSFT   406.40 (-1.32%)
META   505.22 (+2.24%)
GOOGL   156.46 (+0.64%)
AMZN   179.56 (-0.95%)
TSLA   150.71 (-3.05%)
NVDA   847.06 (+0.80%)
AMD   154.65 (+0.41%)
NIO   4.01 (+2.56%)
BABA   68.93 (+0.16%)
T   16.25 (+0.81%)
F   12.03 (-0.08%)
MU   113.06 (-2.81%)
GE   154.10 (-1.01%)
CGC   8.15 (+25.58%)
DIS   112.96 (+0.02%)
AMC   2.91 (-2.35%)
PFE   25.33 (-0.35%)
PYPL   62.35 (-1.44%)
XOM   118.36 (-0.23%)
QQQ   424.07 (-0.42%)
AAPL   166.99 (-0.60%)
MSFT   406.40 (-1.32%)
META   505.22 (+2.24%)
GOOGL   156.46 (+0.64%)
AMZN   179.56 (-0.95%)
TSLA   150.71 (-3.05%)
NVDA   847.06 (+0.80%)
AMD   154.65 (+0.41%)
NIO   4.01 (+2.56%)
BABA   68.93 (+0.16%)
T   16.25 (+0.81%)
F   12.03 (-0.08%)
MU   113.06 (-2.81%)
GE   154.10 (-1.01%)
CGC   8.15 (+25.58%)
DIS   112.96 (+0.02%)
AMC   2.91 (-2.35%)
PFE   25.33 (-0.35%)
PYPL   62.35 (-1.44%)
XOM   118.36 (-0.23%)
QQQ   424.07 (-0.42%)
AAPL   166.99 (-0.60%)
MSFT   406.40 (-1.32%)
META   505.22 (+2.24%)
GOOGL   156.46 (+0.64%)
AMZN   179.56 (-0.95%)
TSLA   150.71 (-3.05%)
NVDA   847.06 (+0.80%)
AMD   154.65 (+0.41%)
NIO   4.01 (+2.56%)
BABA   68.93 (+0.16%)
T   16.25 (+0.81%)
F   12.03 (-0.08%)
MU   113.06 (-2.81%)
GE   154.10 (-1.01%)
CGC   8.15 (+25.58%)
DIS   112.96 (+0.02%)
AMC   2.91 (-2.35%)
PFE   25.33 (-0.35%)
PYPL   62.35 (-1.44%)
XOM   118.36 (-0.23%)
QQQ   424.07 (-0.42%)
AAPL   166.99 (-0.60%)
MSFT   406.40 (-1.32%)
META   505.22 (+2.24%)
GOOGL   156.46 (+0.64%)
AMZN   179.56 (-0.95%)
TSLA   150.71 (-3.05%)
NVDA   847.06 (+0.80%)
AMD   154.65 (+0.41%)
NIO   4.01 (+2.56%)
BABA   68.93 (+0.16%)
T   16.25 (+0.81%)
F   12.03 (-0.08%)
MU   113.06 (-2.81%)
GE   154.10 (-1.01%)
CGC   8.15 (+25.58%)
DIS   112.96 (+0.02%)
AMC   2.91 (-2.35%)
PFE   25.33 (-0.35%)
PYPL   62.35 (-1.44%)
XOM   118.36 (-0.23%)
OTCMKTS:PARNF

Parnell Pharmaceuticals (PARNF) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PARNF stock logo

About Parnell Pharmaceuticals Stock (OTCMKTS:PARNF)

Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.

PARNF Stock News Headlines

Next President (Not Trump. Not Biden.)
Do you want to see who I believe will be the next president of the U.S.A? It won't be Biden… And it won't be Trump.
Parnell Pharmaceuticals Holdings Ltd (PARNF)
The best Netflix original movies right now
Next President (Not Trump. Not Biden.)
Do you want to see who I believe will be the next president of the U.S.A? It won't be Biden… And it won't be Trump.
PARNF - Parnell Pharmaceuticals Holdings Ltd
See More Headlines
Receive PARNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Parnell Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/18/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:PARNF
Previous Symbol
NASDAQ:PARN
CIK
N/A
Fax
N/A
Employees
78
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$25.80 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Alan Richard Bell (Age 68)
    Executive Chairman
  • Mr. Brad R. McCarthy CPA (Age 48)
    CEO, CFO, Chief Accounting Officer, Company Secretary & Executive Director

PARNF Stock Analysis - Frequently Asked Questions

How do I buy shares of Parnell Pharmaceuticals?

Shares of PARNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PARNF) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners